ETRA — Electra Therapeutics Inc.

ETRA closed at $8.37 (-3.90%) on Oct 26, 2026. Recent offering filing (S-1MEF, Sep 2026). Latest SEC filing: SCHEDULE 13G on Sep 29, 2026.

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Chart, dilution, float and news for ETRA in the TickerWise workspace.

Electra Therapeutics, Inc. is a clinical stage biotechnology company. It is engaged in therapies against novel targets for diseases in immunology and cancer. The company was founded by Adam Rosenthal on October 11, 2018 and is headquartered in South San Francisco, CA.

Company profile

• Sector: Healthcare
• Industry: Medical - Pharmaceuticals
• Country: US
• Exchange: NASDAQ
• Employees: 46
• Website: http://www.electra-therapeutics.com

Latest SEC filings for ETRA

• 2026-09-29SCHEDULE 13G
• 2026-09-29SCHEDULE 13G
• 2026-09-25SCHEDULE 13D
• 2026-09-223
• 2026-09-21S-8
• 2026-09-183
• 2026-09-183
• 2026-09-18CERT
• 2026-09-183
• 2026-09-183

Related companies

• ONC — BeOne Medicines Ltd.
• LQDA — Liquidia Corporation
• DFTX — Definium Therapeutics, Inc.
• AVLN — Avalyn Pharma Inc. Common Stock
• LTGO — Latigo Biotherapeutics Inc.
• LFMDP — LifeMD, Inc.
• CGEM — Cullinan Therapeutics, Inc.
• CUVL — Clinuvel Pharmaceuticals Ltd.

Opening the full analysis uses 1 of your 3 free tickers today.

Open full analysis

Educational tool only — not investment advice.